Literature DB >> 1850051

Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.

M van Zijl1, G Wensvoort, E de Kluyver, M Hulst, H van der Gulden, A Gielkens, A Berns, R Moormann.   

Abstract

To investigate whether live attenuated pseudorabies virus (PRV) can be used as a vaccine vector, PRV recombinants that expressed envelope glycoprotein E1 of hog cholera virus (HCV) were generated. Pigs inoculated with these recombinants developed high levels of neutralizing antibodies against PRV and HCV and were protected against both pseudorabies and hog cholera (classical swine fever).

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1850051      PMCID： PMC240645     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  26 in total

1.  Pseudorabies virus as a live virus vector for expression of foreign genes.

Authors:  D R Thomsen; K R Marotti; D P Palermo; L E Post
Journal:  Gene       Date:  1987       Impact factor: 3.688

2.  Electron microscopic studies of the DNA of defective and standard pseudorabies virions.

Authors:  A S Rubenstein; A S Kaplan
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

3.  Immunoaffinity purification and characterization of the envelope protein E1 of hog cholera virus.

Authors:  G Wensvoort; J Boonstra; B G Bodzinga
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

4.  Establishment, viral susceptibility and biological characteristics of a swine kidney cell line SK-6.

Authors:  L Kasza; J A Shadduck; G J Christofinis
Journal:  Res Vet Sci       Date:  1972-01       Impact factor: 2.534

5.  Intranasal vaccination of pigs against Aujeszky's disease. 1. Comparison of intranasal and parenteral vaccination with an attenuated vaccine in 12-week-old pigs from immunized dams.

Authors:  P W de Leeuw; J M Wijsmuller; J W Zantinga; M J Tielen
Journal:  Vet Q       Date:  1982-04       Impact factor: 3.320

6.  Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein E1.

Authors:  R J Moormann; P A Warmerdam; B van der Meer; W M Schaaper; G Wensvoort; M M Hulst
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

7.  Identification of two genes in the unique short region of pseudorabies virus; comparison with herpes simplex virus and varicella-zoster virus.

Authors:  M van Zijl; H van der Gulden; N de Wind; A Gielkens; A Berns
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

8.  The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus.

Authors:  C Terpstra; M Bloemraad; A L Gielkens
Journal:  Vet Microbiol       Date:  1984-04       Impact factor: 3.293

9.  Molecular cloning and nucleotide sequence of the genome of hog cholera virus.

Authors:  G Meyers; T Rümenapf; H J Thiel
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

10.  Hog cholera virus: identification and characterization of the viral RNA and the virus-specific RNA synthesized in infected swine kidney cells.

Authors:  R J Moormann; M M Hulst
Journal:  Virus Res       Date:  1988-11       Impact factor: 3.303
View more
  51 in total

1.  Classical swine fever virus diagnostics and vaccine production in insect cells.

Authors:  M M Hulst; R J Moormann
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.

Authors:  Yimin Wang; Jin Yuan; Xin Cong; Hua-Yang Qin; Chun-Hua Wang; Yongfeng Li; Su Li; Yuzi Luo; Yuan Sun; Hua-Ji Qiu
Journal:  Clin Vaccine Immunol       Date:  2015-08-26

3.  Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines.

Authors:  M N Widjojoatmodjo; H G van Gennip; A Bouma; P A van Rijn; R J Moormann
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor.

Authors:  Christiane Fetzer; Birke Andrea Tews; Gregor Meyers
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1.

Authors:  G Kühnle; A Heinze; J Schmitt; K Giesow; G Taylor; I Morrison; F A Rijsewijk; J T van Oirschot; G M Keil
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.

Authors:  Yi-Gang Xu; Xue-Ting Guan; Zhong-Mei Liu; Chang-Yong Tian; Li-Chun Cui
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

7.  Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination.

Authors:  Yigang Xu; Lichun Cui; Changyong Tian; Guocai Zhang; Guicheng Huo; Lijie Tang; Yijing Li
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

8.  Enzyme-linked immunosorbent assay using a virus type-specific peptide based on a subdomain of envelope protein E(rns) for serologic diagnosis of pestivirus infections in swine.

Authors:  J P Langedijk; W G Middel; R H Meloen; J A Kramps; J A de Smit
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 9.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Use of lambda gt11 and monoclonal antibodies to map the gene for the 60,000 dalton glycoprotein of infectious laryngotracheitis virus.

Authors:  K Kongsuwan; M A Johnson; C T Prideaux; M Sheppard
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.